发明申请
US20220072014A1 PHARMACEUTICAL COMPOSITION WHICH COMPRISES THE COMBINATION OF A SELECTIVE INHIBITOR OF CYCLOOXYGENASE 2 AND A CARBAMATE DERIVED FROM GUAIFENESIN FOR TREATING PAIN, INFLAMMATION AND MUSCULAR CONTRACTION
有权
基本信息:
- 专利标题： PHARMACEUTICAL COMPOSITION WHICH COMPRISES THE COMBINATION OF A SELECTIVE INHIBITOR OF CYCLOOXYGENASE 2 AND A CARBAMATE DERIVED FROM GUAIFENESIN FOR TREATING PAIN, INFLAMMATION AND MUSCULAR CONTRACTION
- 申请号：US17291169 申请日：2019-11-01
- 公开(公告)号：US20220072014A1 公开(公告)日：2022-03-10
- 发明人： Patricia del Carmen Garcia Armenta , Jose Alonso Chavez Garcia
- 申请人： Federico Amezcua Amezcua , Carlos Amezcua Amezcua
- 申请人地址： MX Guadalajara, Jalisco; MX Guadalajara, Jalisco
- 专利权人： Federico Amezcua Amezcua,Carlos Amezcua Amezcua
- 当前专利权人： Federico Amezcua Amezcua,Carlos Amezcua Amezcua
- 当前专利权人地址： MX Guadalajara, Jalisco; MX Guadalajara, Jalisco
- 优先权： MXMX/A/2018013458 20181105
- 国际申请： PCT/MX2019/000117 WO 20191101
- 主分类号： A61K31/635
- IPC分类号： A61K31/635 ; A61K31/27 ; A61K31/415 ; A61P21/02
摘要：
The present invention refers to a pharmaceutical combination comprising the synergic combination of a selective cyclooxygenase-2 inhibitor, such as the active principle celecoxib and pharmaceutically acceptable salts thereof, and a guaifenesin-derived carbamate such as the active principle methocarbamol and pharmaceutically acceptable salts thereof, formulated with pharmaceutically acceptable excipients and/or carriers and/or additives, in a single dosing unit to be administered orally, dermally or transdermally or topically, indicated for the treatment of pain, inflammation and muscular contractions; said combination triggers a triple effect: analgesic, anti-inflammatory and muscle relaxant, being better tolerated and with less adverse effects in patients with pain, inflammation and muscular contractions.
IPC结构图谱:
| A | 人类生活必需 |
| --A61 | 医学或兽医学；卫生学 |
| ----A61K | 医用、牙科用或梳妆用的配制品 |
| ------A61K31/00 | 含有机有效成分的医药配制品 |
| --------A61K31/33 | .杂环化合物 |
| ----------A61K31/635 | ..有1个杂环的，例如水杨酸偶氮磺胺吡啶 |